3.0.0 5501 2022-10-28T01:46:13Z 2022-10-28T01:46:13Z House HR 2019-12-19 116 [Congressional Record Volume 165, Number 206 (Thursday, December 19, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SCHAKOWSKY:H.R. 5501.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3The Congress shall have Power . . . To regulate Commercewith foreign Nations, and among the several States, and withthe Indian Tribes.[Page H12291]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-12-20T17:55:23Z Referred to 2019-12-19T14:04:40Z Affordable Drug Manufacturing Act of 2020 116 3162 S 2020-01-08 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Related bill CRS 2019-12-20 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-12-19 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-12-19 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-12-19 Introduced in House IntroReferral 1000 9 Library of Congress S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 N Health Competition and antitrust Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Executive agency funding and structure Federal officials Government employee pay, benefits, personnel management Health care costs and insurance Health care coverage and access Health care quality Health programs administration and funding Inflation and prices Licensing and registrations Manufacturing Prescription drugs Public contracts and procurement Public participation and lobbying Health 00 2019-12-19 Introduced in House 2021-09-03T15:03:41Z Affordable Drug Manufacturing Act of 2019

This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.

]]> Affordable Drug Manufacturing Act of 2019 Display Title Affordable Drug Manufacturing Act of 2019 Official Title as Introduced To amend the Public Health Service Act to establish an Office of Drug Manufacturing. Introduced in House IH Short Title(s) as Introduced Affordable Drug Manufacturing Act of 2019 Introduced in House IH Introduced in House 2019-12-19T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr5501ih/xml/BILLS-116hr5501ih.xml 2019-12-20 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.